S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 63,945.57 +0.07%
Next Bullish Trade
Sign in
IQV

IQVIA Holdings, Inc. IQV

$206.26 -4.23 (-2.01%)
Extended · +1.12σ
Mkt cap $34.4B
P/E 25.7
Day $205.80 – $211.64
52wk $154.50 – $244.16
Avg vol
Beta
Div yld
Next earnings

Quick read

Plain English

IQVIA Holdings, Inc. is a healthcare company listed in the US.

IQV last traded at $206.26, down 2.0% on the day; that's in the middle part of its 52-week range ($154.50–$244.16). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →
21 EMA +1 ATR +2 ATR −2 ATR
O H L C

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 63), the trend is strong (ADX 27), and volume is about normal (0.8×). On the business side, revenue is growing 8% year over year and the business keeps about 14 cents of every sales dollar as free cash.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI
63
0–100 · <30 oversold
Trend strength · ADX
27
>25 = strong trend
Volume vs avg
0.84×
1× = average
Stretch from avg
+1.0 ATR
− below · + above
Zone touches
0
tests of this zone
Suggested hold
3–30
bars (≈ days)
Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Revenue growth
+8.4%
year over year
Free-cash-flow margin
14.0%
cash kept per $ of sales
Debt / equity
2.54
lower = less leveraged
P/E ratio
25.7
price ÷ yearly profit

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $208.39 (fair range $132–$293); today's price leaves a +1% cushion below that estimate. The model's verdict is “Fair” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)
$208.39
Fair-value range
$131.92 – $293.17
Margin of safety
+1%
Verdict
Fair
Accounting quality Weak
  • ✓ Positive retained earnings
  • ⚠ Debt exceeds cash
  • ⚠ Quick ratio 0.45 (fragile)
  • ⚠ Debt/equity 3.59 (fragile)
  • ⚠ Goodwill 55% of assets (acquisition-heavy)

Price implies ~8% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

IQV is a $34.4 billion company, priced at 26× last year's earnings.

Mkt cap $34.4B
P/E ttm 25.7
Fwd P/E
Beta
Day range $205.80 – $211.64
52w range $154.50 – $244.16
Avg vol
RSI(2) 30.1
ROE
Net mgn
FCF mgn 14.0%
Debt/Eq 2.54
Div yld
Sector Healthcare
Industry Diagnostics & Research
Next earn
52-week range · today's price
$154.50$244.16

More on IQV